Filed: 11/14/2025ACC: 0000905148-25-004034
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $176.40M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$176.40M
Total AUM (reported)
21.07M
Total Shares
Allocation by class
COM$168.71M95.6%
COM NEW$7.69M4.4%
Portfolio Concentration
Top 3$151.93M86.1%
4–10$24.47M13.9%
Top 3 weight
86.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 21.07M
Sole
Full voting authority
21.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
PHARVARIS N V
SOLEShares4.64M
TypeSH
Market value$115.75M
65.62%
Sole
4.64M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares4.62M
TypeSH
Market value$18.43M
10.45%
Sole
4.62M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$17.75M
10.06%
Sole
9.70M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares489.19K
TypeSH
Market value$13.48M
7.64%
Sole
489.19K
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares473.48K
TypeSH
Market value$7.69M
4.36%
Sole
473.48K
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares1.15M
TypeSH
Market value$3.30M
1.87%
Sole
1.15M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHARVARIS N VSOLE | COM | 4.64M | SH | $115.75M 65.62% | 4.64M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 4.62M | SH | $18.43M 10.45% | 4.62M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $17.75M 10.06% | 9.70M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 489.19K | SH | $13.48M 7.64% | 489.19K | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM NEW | 473.48K | SH | $7.69M 4.36% | 473.48K | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 1.15M | SH | $3.30M 1.87% | 1.15M | 0.00 | 0.00 |